Purkinje cells are heavily related to Essential Tremor
|
Purkinje cells are some of the largest, most visually striking, and structurally complex neurons in the human brain. Discovered in 1837 by Czech anatomist Jan Evangelista Purkyně, these cells reside exclusively in the cerebellum, the region at the base of the brain responsible for motor control, balance, and coordination. Despite making up only a tiny fraction of the brain's total volume, Purkinje cells are the master regulators of all physical movement, acting as the sole output channel for the cerebellar cortex.
|
The Role of Purkinje Cells (Purkinje Neurons) in Essential TremorPathological dysfunction, structural degeneration, and altered firing patterns within these cells disrupt the cerebellum's feedback loop, leading to the characteristic rhythmic, uncontrollable shaking seen in Essential Tremor patients.
Cellular Loss:
Post-mortem brain studies highlight a clear pathology of Purkinje cell loss and structural degradation in people who had ET compared to healthy controls. Misfiring Patterns: Research has shown that Purkinje cells trigger involuntary shaking when their regular, smooth signaling patterns warp into sudden, rhythmic bursts of electrical activity. Reduced Inhibition: The loss or degeneration of these cells reduces the essential "braking system" of the motor cortex, generating the highly patterned physical oscillations known as tremors. Structural Abnormalities: ET brains often present physical deformities in remaining Purkinje cells, such as regular swelling of the axons (known as torpedoes) and severe shrinking of their dendritic trees. The "Purkinjopathy" Classification: Due to these widespread localized defects, many scientists categorize ET as a "Purkinjopathy"—a disorder centered primarily on the degeneration of Purkinje neurons. What is another name for Purkinje cells? Purkinje cells or Purkinje neurons, named for Czech physiologist Jan Evangelista Purkyně who identified them in 1837, are a unique type of prominent, large neuron located in the cerebellar cortex of the brain. |
|
Therapeutic Connections The foundation details that traditional ET pharmacotherapies aim to enhance GABAergic neurotransmission to manually restore the missing chemical inhibition normally provided by healthy Purkinje cells. Furthermore, surgical treatments like Deep Brain Stimulation (DBS) work directly on the downstream cerebellar pathways to override or shut down the abnormal burst signals generated by misfiring Purkinje microcircuits. Why This Research Matters Historically, ET was often dismissed as a functional tremor with no structural cause. By compiling and promoting medical research on cerebellar degeneration, the Diann Shaddox Foundation supports initiatives to treat ET through targets in the cerebellum. Proving that Purkinje cell loss triggers the disease shifts the focus toward developing neuroprotective therapies aimed at slowing down this cellular degeneration. |